Human medicines European public assessment report (EPAR): Striascan, ioflupane (123l), Date of authorisation: 25/06/2019, Revision:...
The active substance in Striascan, ioflupane (123I), is a radiopharmaceutical. It contains a substance called ioflupane, which is labelled with 123I (iodine 123), a radioactive form of iodine. Ioflupane attaches specifically to structures on nerve cell …